Tingting Mei

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dynamics of peripheral immune signature identified by multi-omics and its impact on recurrence after radiofrequency ablation of hepatocellular carcinoma.

Dynamics of peripheral immune signature identified by multi-omics and its impact on recurrence after radiofrequency ablation of hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: December 04, 2025

Traditional Cox regression outperforms large language models in predicting long-term progression of intermediate to advanced hepatocellular carcinoma.

Traditional Cox regression outperforms large language models in predicting long-term progression of intermediate to advanced hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: September 22, 2025

Efficacy and safety of transcatheter arterial embolization combined with ablation and regorafenib for unresectable hepatocellular carcinoma patients failing first-line treatment: a real-world study.

Efficacy and safety of transcatheter arterial embolization combined with ablation and regorafenib for unresectable hepatocellular carcinoma patients failing first-line treatment: a real-world study.

Journal: Journal of gastrointestinal oncology

Published: April 29, 2025

Meta-analysis: accuracy of the Baveno VI criteria for the diagnosis of high-risk varices in patients with hepatocellular carcinoma.

Meta-analysis: accuracy of the Baveno VI criteria for the diagnosis of high-risk varices in patients with hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: August 18, 2024

The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patients.

The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patients.

Journal: The oncologist

Published: April 23, 2024

Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model.

Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model.

Journal: Journal of hepatocellular carcinoma

Published: April 12, 2024

The hepatocellular carcinoma risk in patients with HBV-related cirrhosis: a competing risk nomogram based on a 4-year retrospective cohort study.

The hepatocellular carcinoma risk in patients with HBV-related cirrhosis: a competing risk nomogram based on a 4-year retrospective cohort study.

Journal: Frontiers in oncology

Published: March 11, 2024

Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction.

Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction.

Journal: Expert review of molecular diagnostics

Published: September 06, 2023

Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis.

Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis.

Journal: Lipids in health and disease

Published: May 09, 2023

Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy.

Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy.

Journal: Frontiers in oncology

Published: November 23, 2022

External validation and improvement of the scoring system for predicting the prognosis in hepatocellular carcinoma after interventional therapy.

External validation and improvement of the scoring system for predicting the prognosis in hepatocellular carcinoma after interventional therapy.

Journal: Frontiers in surgery

Published: September 15, 2022

Evaluation of blood-based PRO-C3 testing as a diagnostic marker for staging liver fibrosis: A systematic review and meta-analysis.

Evaluation of blood-based PRO-C3 testing as a diagnostic marker for staging liver fibrosis: A systematic review and meta-analysis.

Journal: Journal of gastroenterology and hepatology

Published: August 30, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026